U.S., May 17 -- ClinicalTrials.gov registry received information related to the study (NCT06976853) titled 'Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease' on April 30.
Brief Summary: The purpose of this research study is to evaluate what type of treatment will be beneficial for people with Crohn's disease and difficult to treat inflammation in the small bowel. Current therapies are used to control the inflammation due to Crohn's disease in your digestive tract. In some patients, those therapies are not sufficient to fully treat the disease. This objective of this study is to evaluate the efficacy of a different type of therapy, tirzepatide, that may promote healing of the affected intestinal segment. To evaluate th...